
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
NONE. Menrva holds no usable description for this book. Unless you genuinely and specifically know this published work, set sufficient_material=false. Do NOT infer a plot, characters, or contents from the title.
This book investigates the mechanisms by which breast cancer cells induce apoptosis, focusing on the role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and the phenomenon of breast cancer resistance. It examines the complex interplay between cellular signaling pathways, the expression of death receptors, and the evasion strategies employed by cancer cells to survive treatment. The research synthesizes current understanding of TRAIL-mediated apoptosis and its therapeutic implications in the context of drug resistance.
This specialized text is likely to be of significant interest to researchers and clinicians actively involved in oncology, molecular biology, and cancer therapeutics. Its focus on specific molecular mechanisms suggests a dense, technical presentation aimed at an informed audience. The detailed examination of TRAIL and apoptosis in breast cancer resistance indicates a contribution to the ongoing scientific discourse on novel treatment approaches.
Page Count:
152
Publication Date:
2023-01-25
Publisher:
LAP LAMBERT Academic Publishing
ISBN-10:
6205633388
ISBN-13:
9786205633380
No comments yet. Be the first to share your thoughts!